Antares Pharma, Inc. Announces the Issuance of a New U.S. Patent on the VIBEX® Device Platform

Published: Oct 25, 2013

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

EWING, N.J.--(BUSINESS WIRE)--Antares Pharma, Inc. (NASDAQ: ATRS) today announced the issuance of U.S. Patent number 8,562,564, entitled “Prefilled Syringe Jet Injector”. This patent adds to a comprehensive portfolio of patents and applications that are intended to protect Antares’ auto injector technology and product pipeline including the VIBEX® Medi-Jet™ device and the VIBEX® Quick Shot™ (QS) technology. This new patent is designed to protect the use of medicament containing prefilled syringe based auto-injectors, such as those used in OTREXUP™ and QS T (in development for testosterone deficiency).

Help employers find you! Check out all the jobs and post your resume.

Back to news